FMKT yields 2.25% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, FMKT + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FMKT + PFE for your $10,000?
FMKT is an actively managed fund that aims to capitalize on US listed equities that are anticipated to benefit from regulatory shifts favoring free market dynamics. The fund targets sectors burdened by high regulation like healthcare, financial services, and energy, predicting regulatory relief. Investments also span technology and consumer goods sectors less affected by regulation. Examples of favorable shifts include deregulation, reduced taxes, licensing reforms, and tariffs elimination. The Fund seeks value by leveraging expected regulatory reforms, aiming to buffer against increased regulatory burdens. The selection process evaluates companies poised for deregulation benefits, focusing on their adaptability, strategies, and competitive positioning within industries. The portfolio generally consists of 25-50 positions, investing at least 80% in deregulation beneficiaries. Up to 5% may be invested in ETPs with exposure to Bitcoin and Ether, enhancing diversification and seizing digital asset growth opportunities.
Full FMKT Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.